PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-66.33%
Both yoy net incomes decline, with MCHP at -62.48%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
-3.06%
Both reduce yoy D&A, with MCHP at -1.57%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-160.50%
Negative yoy deferred tax while MCHP stands at 14818.18%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
182.05%
SBC growth while MCHP is negative at -1.44%. John Neff would see competitor possibly controlling share issuance more tightly.
2892.00%
Well above MCHP's 51.93% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
2016.67%
AR growth while MCHP is negative at -192.37%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
145.95%
Inventory growth well above MCHP's 116.99%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
277.60%
AP growth well above MCHP's 166.23%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
-43.16%
Negative yoy usage while MCHP is 80.75%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-1044.00%
Negative yoy while MCHP is 3.37%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-9.73%
Negative yoy CFO while MCHP is 83.16%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
36.00%
CapEx growth well above MCHP's 38.24%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
55.46%
Purchases well above MCHP's 29.89%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
194.30%
We have some liquidation growth while MCHP is negative at -17.56%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
No Data
No Data available this quarter, please select a different quarter.
86.88%
Investing outflow well above MCHP's 69.51%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
100.00%
Debt repayment growth of 100.00% while MCHP is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
111.11%
Stock issuance far above MCHP's 15.63%. Michael Burry flags a significant dilution risk vs. competitor’s approach unless ROI is very high.
No Data
No Data available this quarter, please select a different quarter.